MKMarie Kempf

Marie Kempf

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marie Kempf has a total of 278 co-authors. Here are the top co-authors by number of shared publications:

  • Marie-Laure Joly-Guillou

    Département des agents infectieux, Centre hospitalier universitaire, 4, rue Larrey, 49933 Angers cedex 9

    17 shared publications
  • Matthieu Eveillard

    Laboratory of Bacteriology, CHU Angers, Angers, France

    10 shared publications
  • Carole Lemarié

    Laboratory of Bacteriology, CHU Angers, Angers, France

    7 shared publications
  • Hélène Pailhoriès

    Département de Biologie des Agents Infectieux, UF de Bactériologie-Hygiène, Centre Hospitalier Universitaire Angers, France; HIFIH Laboratoire UPRES EA3859, SFR ICAT 4208 Université Angers, Angers, France

    6 shared publications
  • Monzer Hamze

    Laboratoire Microbiologie Santé et Environnement (LMSE), Ecole Doctorale des Sciences et de Technologie et Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon

    6 shared publications
  • Hélène Pailhoriès

    Laboratoire HIFIH, UPRES EA3859, SFR 4208, Université d’Angers, 49933 Angers, France

    4 shared publications

Latest Publications

  • Antimicrobial activity of new anti-Pseudomonas beta-lactam-beta-lactamase inhibitors against Pseudomonas aeruginosa respiratory isolates recovered during the study for Monitoring Antimicrobial Resistance Trends (SMART) program in France (2016–2022)

    by Charlie Zins, Hélène Pailhoriès, Rachel Chenouard, Stéphane Corvec, Sandrine Dahyot, Paul-Louis Woerther, Catherine Eckert, Gautier Pierrat, Xavier Bourge, Sophie Boyer, et al.

  • Open Access

    An Overview of 10 Years of Activity of a Molecular Laboratory for Buruli Ulcer Diagnosis at a Field Hospital in Benin

    by Faraj Fajloun, Line Ganlonon, Ronald Sètondji Gnimavo, Espoir Sodjinou, Akimath Habib, Eric Claco, Irvine Agoundoté, Ambroise Adeye, Perrin Catraye, Charbel Al-Bayssari, et al.

    Here, we describe the first 10 years of activity at a field laboratory established at the Buruli ulcer treatment center (CDTLUB) in Pobè, Benin, a country in which Mycobacterium ulcerans is endemic. Between 2012 and 2022, the laboratory analyzed 3,018 samples from patients consulting the CDTLUB of Pobè with a suspected clinical BU.


  • Open Access

    Overexpression of an apple broad range agglutinating lectin does not promote in planta resistance to fire blight and bacterial wilt

    by Antoine Bodelot, Erwan Chavonet, Marie Noelle Brisset, Nicolas Dousset, Elisa Ravon, Christelle Heintz, Richard Berthomé, Mathilda Zaffuto, Marie Kempf, Mélanie Foulon, et al.

    Lectins, a large group of proteins present in all kingdoms of life can bind reversibly to glycans. The roles of plant lectins are diverse and include resistance to biotic or abiotic stress, notably bacterial resistance. A gene family encoding amaranthin-like lectins termed MdAGGs in apple ( Malus domestica ) has been identified to be overexpressed upon treatment with the plant resistance inducer acibenzolar-S-methyl (ASM) which promotes enhanced resistance to the fire blight disease caused by Erwinia amylovora ( Ea ). In this study, we first screened the ability of purified MdAGG10 to agglutinate bacterial cells in vitro among a range of bacterial species. Several bacterial species, either Gram positive or negative, either plant- or human-pathogens were found to be agglutinated by MdAGG10 in acidic conditions. Apple and Arabidopsis lines constitutively overexpressing MdAGG10 were generated and evaluated for their resistance to, respectively, Ea and Ralstonia solanacearum , both plant pathogens that were found in our screening. Despite MdAGG10 protein accumulated in tissues of both apple and Arabidopsis lines, they remained susceptible to their respective pathogens. Interestingly, in vitro agglutination of Ea by MdAGG10 did not impair bacterial growth, suggesting that other plant molecules are involved in the resistance to fire blight triggered after an ASM treatment.


  • Open Access

    Importance of consultations using mobile teams in the screening and treatment of neglected tropical skin diseases in Benin

    by Ronald Sètondji Gnimavo, Faraj Fajloun, Charbel Al-Bayssari, Espoir Sodjinou, Akimath Habib, Line Ganlonon, Eric Claco, Irvine Agoundoté, Odile Adjouavi Houngbo, Esaï Gimatal Anagonou, et al.

    Since 2013, the World Health Organization has recommended integrated control strategies for neglected tropical diseases (NTDs) with skin manifestations. We evaluated the implementation of an integrated approach to the early detection and rapid treatment of skin NTDs based on mobile clinics in the Ouémé and Plateau areas of Benin. This descriptive cross-sectional study was performed in Ouémé and Plateau in Benin from 2018 to 2020. Consultations using mobile teams were performed at various sites selected by reasoned choice based on the epidemiological data of the National Program for the Control of Leprosy and Buruli Ulcer. All individuals presenting with a dermatological lesion who voluntarily approached the multidisciplinary management team on the day of consultation were included. The information collected was kept strictly anonymous and was entered into an Excel 2013 spreadsheet and analyzed with Stata 11 software. In total, 5,267 patients with various skin conditions consulted the medical team. The median age of these patients was 14 years (IQR: 7–34 years). We saw 646 (12.3%) patients presenting NTDs with skin manifestations, principally scabies, in 88.4% (571/646), followed by 37 cases of Buruli ulcer (5.8%), 22 cases of leprosy (3.4%), 15 cases of lymphatic filariasis (2.3%) and one case of mycetoma (0.2%). We detected no cases of yaws. This sustainable approach could help to decrease the burden of skin NTDs in resource-limited countries. Neglected Tropical Diseases (NTDs) with skin manifestations are a group of nine infectious diseases with skin manifestations, either as the primary symptom or as an associated clinical feature. They are often co-endemic and harbor similar clinical signs. We evaluated the implementation of an integrated approach to the early detection and rapid treatment of skin NTDs based on consultations using mobile teams in the départements of Ouémé and Plateau in Benin. In total, 5,267 patients with various skin conditions consulted. We saw 646 (12.3%) patients presenting NTDs with skin manifestations and among them, 571 (88.4%) had scabies, 37 (5.8%) had Buruli ulcer, 22 (3.4%) had leprosy, 15 (2.3%) had lymphatic filariasis and 1 (0.2%) had mycetoma. Consultations using mobile teams constitute a very efficient strategy for the integrated screening of skin diseases and especially of NTDs with skin manifestations. This sustainable approach could help to decrease the burden of NTDs in resource-limited countries.


  • Implementation of a new blood cultures sampling strategy in patients receiving intensive chemotherapy for acute leukemia and/or hematopoietic cell transplantation

    by Charles Declerck, Aurélien Giltat, Romane Boutemy, Marie Brisset-Dheilly, Anais Pelhatre, Mathilde Hunault-Berger, Marie Kempf, Achille Kouatchet, Raphael Mahieu, Aline Tanguy-Schmidt, et al.

    Fever is frequent during intensive chemotherapy for patients with hematological malignancies, and although a pathogen is identified in only 25% of cases, the recognition of bacteremias is crucial a...


  • Open Access

    Genetic Diversity and Population Structure of Mycobacterium bovis at the Human-Animal-Ecosystem Interface in France: “A One Health Approach”

    by Anaïs Appegren, Maria Laura Boschiroli, Krystel De Cruz, Lorraine Michelet, Geneviève Héry-Arnaud, Marie Kempf, Philippe Lanotte, Pascale Bemer, Olivia Peuchant, Martine Pestel-Caron, et al.

    Mycobacterium bovis infects cattle and wildlife, and also causes a small proportion of tuberculosis cases in humans. In most European countries, M. bovis infections in cattle have been drastically reduced, but not eradicated. Here, to determine the M. bovis circulation within and between the human, cattle, and wildlife compartments, we characterized by spoligotyping and mycobacterial interspersed repetitive unit-variable number tandem repeat (MIRU-VNTR) typing the genetic diversity of M. bovis isolates collected from humans, cattle, and wildlife in France from 2000 to 2010. We also assessed their genetic structure within and among the different host groups, and across time and space. The M. bovis genetic structure and its spatiotemporal variations showed different dynamics in the human and animal compartments. Most genotypes detected in human isolates were absent in cattle and wildlife isolates, possibly because in patients, M. bovis infection was contracted abroad or was the reactivation of an old lesion. Therefore, they did not match the genetic pool present in France during the study period. However, some human-cattle exchanges occurred because some genotypes were common to both compartments. This study provides new elements for understanding M. bovis epidemiology in France, and calls for increased efforts to control this pathogen worldwide.


  • Open Access

    Commiphora wildii Merxm. Essential Oil: Natural Heptane Source and Co-Product Valorization

    by Djallel Mansouri, Anne Landreau, Thomas Michel, Clément De Saint Jores, Bienvenue Razafimandimby, Marie Kempf, Stéphane Azoulay, Nicolas Papaiconomou, Xavier Fernandez

    As an alternative to fossil volatile hydrocarbon solvents used nowadays in perfumery, investigation on essential oil of Commiphora wildii Merxm. oleo gum resin as a source of heptane is reported here. Heptane, representing up to 30 wt-% of this oleo gum resin, was successfully isolated from the C. wildii essential oil, using an innovative double distillation process. Isolated heptane was then used as a solvent in order to extract some noble plants of perfumery. It was found that extracts obtained with this solvent were more promising in terms of sensory analysis than those obtained from fossil-based heptane. In addition, in order to valorize the essential oil depleted from heptane, chemical composition of this oil was found to obtain, and potential biological activity properties were studied. A total of 172 different compounds were identified by GC-MS in the remaining oil. In vitro tests—including hyaluronidase, tyrosinase, antioxidant, elastase and lipoxygenase, as well as inhibitory tests against two yeasts and 21 bacterial strains commonly found on the skin—were carried out. Overall, bioassays results suggest this heptane-depleted essential oil is a promising active ingredient for cosmetic applications.


  • Caractéristiques cliniques des bactériémies et endocardites dues à Staphylococcus lugdunensis

    by M. de la Chapelle, R. Courtois, C. Deschanvres, P. Danneels, C. Porcher, P. Holescka, M. Kempf, V. Dubée

  • Open Access

    The Right Time to Safely Re-Evaluate Empirical Antimicrobial Treatment of Hip or Knee Prosthetic Joint Infections

    by Luc Deroche, Pascale Bémer, Anne-Sophie Valentin, Anne Jolivet-Gougeon, Didier Tandé, Geneviève Héry-Arnaud, Carole Lemarié, Marie Kempf, Laurent Bret, Christophe Burucoa, et al.

    Currently, no guideline provides recommendations on the duration of empirical antimicrobial treatment (EAT) in prosthetic joint infection (PJI). The aim of our study was to describe the time to growth of bacteria involved in PJI, rendering possible decreased duration of EAT. Based on a French multicentre prospective cohort study, culture data from patients with confirmed hip or knee PJI were analysed. For each patient, five samples were processed. Time to positivity was defined as the first positive medium in at least one sample for virulent pathogens and as the first positive medium in at least two samples for commensals. Definitive diagnosis of polymicrobial infections was considered the day the last bacteria were identified. Among the 183 PJIs, including 28 polymicrobial infections, microbiological diagnosis was carried out between Day 1 (D1) and D5 for 96.7% of cases. There was no difference in the average time to positivity between acute and chronic PJI (p = 0.8871). Microbiological diagnosis was given earlier for monomicrobial than for polymicrobial infections (p = 0.0034). When an optimized culture of peroperative samples was carried out, almost all cases of PJI were diagnosed within five days, including polymicrobial infections. EAT can be re-evaluated at D5 according to microbiological documentation.